Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration

U.S. Food and Drug Administration Approves ABILIFY® (aripiprazole) for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients (Ages 6 to 17 Years)

New addition to CalorieMate® line of balanced nutrition blocks CalorieMate® Block, Maple Flavor First new flavor in two years debuts September 29

New SOYJOY Favored with Blueberries and White Chocolate Chips SOYJOY Blueberry Debuts September 29, 2009

Otsuka Pharmaceutical Supports 8th Annual Wheelchair Basketball Camp in Ibaraki held from August 14-16, 2009

20th Annual Outdoor Concert Held at Otsuka Pharmaceutical Tokushima Wajiki Factory Exciting Summer in Wajiki ’09 on August 13, 2009

The European Commission Approves SAMSCA™ (tolvaptan), Europe’s First and Only Oral Vasopressin Antagonist for Hyponatraemia Secondary to Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH).

Pocari Sweat in 900ml PET Eco-bottles New lightweight eco-bottles achieve 30% reduction in packaging weight

Fiscal Year through March 2009 Non-consolidated Results of Otsuka Pharmaceutical Co., Ltd. (PDF:314KB)

Otsuka Pharmaceutical Co., Ltd. Appoints the Board Members and Statutory Auditors (PDF:162KB)

FDA Approves SAMSCA™ (tolvaptan), The First and Only Oral Vasopressin Antagonist to Treat Patients with Clinically Significant Hypervolemic and Euvolemic Hyponatremia

Otsuka and Bristol-Myers Squibb Extend U.S. Agreement for ABILIFY and Establish a Global Oncology Collaboration

Otsuka Pharmaceutical Special Sponsorship Pocari Sweat U-12 Soccer League

20th Anniversary Edition Published March 31 OTSUKA Health Comic Library Sequel Vol. 2 "Explore! All About Our Bodies" Educational comic series donated to elementary schools nationwide

Make-up removers formulated with moisturizing ingredient AMP expand the InnerSignal line of skin care products gentle, thorough removal of sebum and makeup

Antipsychotic agent ABILIFYR Oral Solution 0.1% to be Launched on April 10, 2009 in Japan

Otsuka Pharmaceutical Supports Anti-Doping Efforts through Participation in “Sports Pharmacist” Project

Third product in fruit soy bar SOYJOY ‘Plus’ series SOYJOY Banana Calcium Plus Debuts April 1, 2009

Produced by Amino-Value “Virtual Tokyo Marathon 2009” Select your favorite avatar and challenge the 42.195km run

Otsuka Pharmaceutical Established Otsuka Shanghai Research Institute in China for Innovative Drug Discovery Research

UL・OS Line of Men's Skincare Launches Sunscreen Formulated with Moisturizing Ingredient AMP Initial launch in Kyushu and Okinawa, February 9